Montgomery D L, Ulmer J B, Donnelly J J, Liu M A
Department of Virus and Cell Biology, Merck Research Laboratories, West Point, PA 19486, USA.
Pharmacol Ther. 1997;74(2):195-205. doi: 10.1016/s0163-7258(97)82003-7.
In just a few years, injection of plasmid DNA to elicit immune responses in vivo has developed from an interesting observation to a viable vaccine strategy. DNA vaccines have been shown to elicit both cellular and humoral immune responses and to be effective in a variety of preclinical bacterial, viral, and parasitic animal models. This review will discuss the current knowledge of vector design, methods of plasmid delivery, immune responses elicited by various DNA vaccines, safety issues, and production and release of plasmid as a vaccine product. The potential of this new vaccine strategy and its future prospects is summarized.
在短短几年内,通过注射质粒DNA在体内引发免疫反应已从一个有趣的观察结果发展成为一种可行的疫苗策略。DNA疫苗已被证明能引发细胞免疫和体液免疫反应,并在多种临床前细菌、病毒和寄生虫动物模型中有效。本综述将讨论载体设计的现有知识、质粒递送方法、各种DNA疫苗引发的免疫反应、安全问题以及作为疫苗产品的质粒的生产和放行。总结了这种新疫苗策略的潜力及其未来前景。